Yun-Ting Kao

Senior Scientist Immunomic Therapeutics, Inc

Seminars

Thursday 26th February 2026
Building Characterization Assays to Support Early-Stage saRNA Development and QC Alignment
2:30 pm
  • Establishing characterization assays that define saRNA product quality and inform key CMC decisions in early development.
  • Ensuring analytical consistency and data integrity when partnering with CROs and CDMOs for assay execution and method transfer.
Yun-Ting Kao Senior Scientist Immunomic Therapeutics